Telavancin Injection

Generic name: Pronounced as (tel' a van sin)
Brand names
  • Vibativ®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 01/15/2017

Telavancin injection can cause kidney damage. Tell your doctor if you have diabetes, heart failure (condition in which the heart is unable to pump enough blood to the other parts of the body), high blood pressure, or kidney disease. Tell your doctor if you are taking angiotensin-converting enzyme (ACE) inhibitors such as benazepril (Lotensin, in Lotrel), captopril, enalapril (Epaned, Vasotec, in Vaseretic), enalaprilat, fosinopril, lisinopril (Prinivil, Zestril, in Zestoretic), moexipril, perindopril (Aceon, in Prestalia), quinapril (Accupril, in Accuretic, Quinaretic), ramipril (Altace), and trandolapril (Mavik, in Tarka); angiotensin receptor blockers (ARBs) such as candesartan (Atacand), eprosartan (Teveten), irbesartan (Avapro, in Avalide), losartan (Cozaar, in Hyzaar), olmesartan (Benicar, in Azor, Tribenzor), telmisartan (Micardis, in Twynsta), and valsartan (Diovan, in Byvalson, Entresto, Exforge); loop diuretics ("water pills") such as bumetanide (Bumex), ethacrynic acid (Edecrin), furosemide (Lasix), and torsemide (Damadex); and nonsteroidal anti-inflammatory medications (NSAIDS) such as ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn). If you experience any of the following symptoms, call your doctor immediately: decreased urination, swelling in your legs, feet, or ankles, confusion, or chest pain or pressure.

Keep all appointments with your doctor and the laboratory. Your doctor will order certain tests before and during your treatment.

Telavancin injection has caused birth defects in animals. This medication has not been studied in pregnant women, but it is possible that it may also cause birth defects in babies whose mothers received telavancin injection during pregnancy. You should not use telavancin injection while you are pregnant or plan to become pregnant unless your doctor decides that this is the best treatment for your infection. If you can become pregnant, you will need to have a pregnancy test before beginning treatment with telavancin injection. You will also need to use an effective form of birth control during your treatment. If you become pregnant while receiving telavancin injection, call your doctor immediately.

Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with telavancin injection. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) or the manufacturer's website to obtain the Medication Guide.

Talk to your doctor about the risks of using telavancin injection.

Telavancin injection is used alone or with other medications to treat serious skin infections caused by certain types of bacteria. It is also used alone or with other medications to treat certain types of pneumonia caused by bacteria when there are no other treatment options available. Telavancin injection is in a class of medications called lipoglycopeptide antibiotics. It works by killing bacteria that cause infection.

Antibiotics such as telavancin injection will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.

Telavancin injection comes as a powder to be mixed with liquid and injected intravenously (into a vein). It is usually infused (injected slowly) over a period of 60 minutes once every 24 hours for 7 to 21 days. The length of your treatment depends on the type of infection you have and how your body responds to the medication.

You may experience a reaction while you receive a dose of telavancin injection, usually during your infusion or soon after your infusion has completed. Tell your doctor immediately if you experience any of these symptoms while you receive telavancin injection: difficulty swallowing or breathing, swelling of your tongue, lips, throat or face, hoarseness, itching, hives, rash, flushing of the upper body, fast heartbeat, or feeling faint or dizzy.

You may receive telavancin injection in a hospital or you may administer the medication at home. If you will be using telavancin injection at home, your healthcare provider will show you how to infuse the medication. Be sure that you understand these directions, and ask your healthcare provider if you have any questions. Ask your healthcare provider what to do if you have any problems infusing telavancin injection.

You should begin to feel better during the first few days of treatment with telavancin injection. If your symptoms do not improve or get worse, tell your doctor.

Use telavancin injection until you finish the prescription, even if you feel better. If you stop using telavancin injection too soon or skip doses, your infection may not be completely treated and the bacteria may become resistant to antibiotics.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before using telavancin injection,

  • tell your doctor and pharmacist if you are allergic to telavancin , vancomycin, any other medications, or any of the ingredients in telavancin injection. Ask your pharmacist or check the Medication Guide for a list of the ingredients.

  • tell your doctor if you are receiving heparin. Your doctor will probably tell you not to use heparin if you are receiving telavancin injection.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: anagrelide (Agrylin); anticoagulants (''blood thinners'') such as warfarin (Coumadin); azithromycin (Zithromax); chlorpromazine; cilostazol; ciprofloxacin (Cipro); citalopram; donepezil (Aricept); dronedarone (Multaq); escitalopram (Lexapro); haloperidol (Haldol); medications that control the heart rhythm or rate such as amiodarone (Cordarone, Nexterone, Pacerone), disopyramide (Norpace), dofetilide (Tikosyn), flecainide (Tambocor), procainamide, quinidine, and sotalol (Betapace, Sorine, Sotylize); levofloxacin (Levaquin); methadone (Dolophine, Methadose); ondansetron (Zofran, Zyplenz); pimozide (Orap); vandetanib (Caprelsa); and thioridazine. Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with telavancin injection, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.

  • tell your doctor if you or anyone in your family has or has ever had a prolonged QT interval (rare heart problem that may cause irregular heartbeat, fainting, or sudden death) and if you have or have ever had heart disease.

  • tell your doctor if you are breastfeeding.

Unless your doctor tells you otherwise, continue your normal diet.

  • Telavancin injection may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • metallic or soapy taste

    • decreased appetite

    • nausea

    • vomiting

    • diarrhea

    • foamy urine

    • chills

    • headache

  • Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately:

    • watery or bloody stools, stomach cramps, or fever up to two or more months after stopping treatment

    • fast or irregular heartbeat

    • fainting

    • return of fever, chills, sore throat, or other signs of infection

  • Telavancin injection may cause other side effects. Call your doctor if you have any unusual problems while using this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Before having any laboratory test, tell your doctor and the laboratory personnel that you are using telavancin injection.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Telavancin.
Dolasetron Dolasetron The risk or severity of QTc prolongation can be increased when Dolasetron is combined with Telavancin.
Anagrelide Anagrelide The risk or severity of QTc prolongation can be increased when Telavancin is combined with Anagrelide.
Cilostazol Cilostazol The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Telavancin.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Telavancin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may decrease the excretion rate of Telavancin which could result in a higher serum level.
Fenofibrate Fenofibrate Fenofibrate may decrease the excretion rate of Telavancin which could result in a higher serum level.
Guanfacine Guanfacine Guanfacine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Magnesium Hydroxide Magnesium Hydroxide Telavancin may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Mycophenolate Mycophenolate Mycophenolic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.
Olsalazine Olsalazine Olsalazine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Penbutolol Penbutolol The risk or severity of QTc prolongation can be increased when Acebutolol is combined with Telavancin.
Potassium Potassium Potassium cation may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone Prednisone Prednisone may decrease the excretion rate of Telavancin which could result in a higher serum level.
Ranitidine Ranitidine Ranitidine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Reserpine Reserpine Reserpine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Rizatriptan Rizatriptan Rizatriptan may decrease the excretion rate of Telavancin which could result in a higher serum level.
Sumatriptan Sumatriptan Sumatriptan may decrease the excretion rate of Telavancin which could result in a higher serum level.
Tacrolimus Tacrolimus Tacrolimus may decrease the excretion rate of Telavancin which could result in a higher serum level.
Tizanidine Tizanidine The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Telavancin.
Ampicillin Injection Ampicillin Injection Ampicillin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Doxycycline may decrease the excretion rate of Telavancin which could result in a higher serum level.
Famotidine Injection Famotidine Injection The risk or severity of QTc prolongation can be increased when Famotidine is combined with Telavancin.
Fluconazole Injection Fluconazole Injection The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Telavancin.
Foscarnet Injection Foscarnet Injection The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Telavancin.
Hydromorphone Injection Hydromorphone Injection Hydromorphone may decrease the excretion rate of Telavancin which could result in a higher serum level.
Levofloxacin Injection Levofloxacin Injection The risk or severity of QTc prolongation can be increased when Levofloxacin is combined with Telavancin.
Meperidine Injection Meperidine Injection Meperidine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Metoclopramide Injection Metoclopramide Injection The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Telavancin.
Metronidazole Injection Metronidazole Injection The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Telavancin.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Telavancin may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Altretamine Altretamine Amphetamine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Telavancin which could result in a higher serum level.
Cyclosporine Cyclosporine Cyclosporine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Ondansetron Ondansetron The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Telavancin.
Enoxaparin Injection Enoxaparin Injection The therapeutic efficacy of Enoxaparin can be decreased when used in combination with Telavancin.
Granisetron Granisetron The risk or severity of QTc prolongation can be increased when Granisetron is combined with Telavancin.
Torsemide Torsemide Torasemide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
Olanzapine Olanzapine The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Telavancin.
Dofetilide Dofetilide The risk or severity of QTc prolongation can be increased when Telavancin is combined with Dofetilide.
Hydroxychloroquine Hydroxychloroquine The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Telavancin.
Meloxicam Meloxicam Meloxicam may decrease the excretion rate of Telavancin which could result in a higher serum level.
Pantoprazole Pantoprazole Pantoprazole may decrease the excretion rate of Telavancin which could result in a higher serum level.
Temozolomide Temozolomide Temozolomide may decrease the excretion rate of Telavancin which could result in a higher serum level.
Zaleplon Zaleplon Zaleplon may decrease the excretion rate of Telavancin which could result in a higher serum level.
Desloratadine Desloratadine The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Telavancin.
Trimipramine Trimipramine The risk or severity of QTc prolongation can be increased when Trimipramine is combined with Telavancin.
Perindopril Perindopril Perindopril may decrease the excretion rate of Telavancin which could result in a higher serum level.
Tenofovir Tenofovir Tenofovir may decrease the excretion rate of Telavancin which could result in a higher serum level.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Telavancin which could result in a higher serum level.
Eplerenone Eplerenone Eplerenone may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
Escitalopram Escitalopram The risk or severity of QTc prolongation can be increased when Telavancin is combined with Escitalopram.
Zonisamide Zonisamide The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Telavancin.
Aripiprazole Aripiprazole The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Telavancin.
Atomoxetine Atomoxetine The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Telavancin.
Atazanavir Atazanavir The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Telavancin.
Almotriptan Almotriptan Almotriptan may decrease the excretion rate of Telavancin which could result in a higher serum level.
Mefloquine Mefloquine The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Telavancin.
Vardenafil Vardenafil The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Telavancin.
Alfuzosin Alfuzosin The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Telavancin.
Emtricitabine Emtricitabine Emtricitabine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Memantine Memantine Memantine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Tadalafil Tadalafil Tadalafil may decrease the excretion rate of Telavancin which could result in a higher serum level.
Gemifloxacin Gemifloxacin The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Telavancin.
Apomorphine Injection Apomorphine Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Telavancin.
Protriptyline Protriptyline The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Telavancin.
Duloxetine Duloxetine Duloxetine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Tinidazole Tinidazole Tinidazole may decrease the excretion rate of Telavancin which could result in a higher serum level.
Cefditoren Cefditoren Cefdinir may decrease the excretion rate of Telavancin which could result in a higher serum level.
Cyanocobalamin Injection Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Erlotinib Erlotinib The risk or severity of QTc prolongation can be increased when Telavancin is combined with Erlotinib.
Eszopiclone Eszopiclone Eszopiclone may decrease the excretion rate of Telavancin which could result in a higher serum level.
Ganciclovir Ganciclovir Ganciclovir may decrease the excretion rate of Telavancin which could result in a higher serum level.
Ribavirin Ribavirin Ribavirin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Solifenacin Solifenacin The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Telavancin.
Valganciclovir Valganciclovir Valganciclovir may decrease the excretion rate of Telavancin which could result in a higher serum level.
Voriconazole Voriconazole The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Telavancin.
Adefovir Adefovir Adefovir may decrease the excretion rate of Telavancin which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine Amphetamine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Ibandronate Ibandronate The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Telavancin.
Ramelteon Ramelteon Ramelteon may decrease the excretion rate of Telavancin which could result in a higher serum level.
Fentanyl Fentanyl Fentanyl may decrease the excretion rate of Telavancin which could result in a higher serum level.
Pregabalin Pregabalin The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Telavancin.
Felbamate Felbamate The risk or severity of QTc prolongation can be increased when Felbamate is combined with Telavancin.
Ranolazine Ranolazine The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Telavancin.
Rasagiline Rasagiline Rasagiline may decrease the excretion rate of Telavancin which could result in a higher serum level.
Imatinib Imatinib The risk or severity of QTc prolongation can be increased when Telavancin is combined with Imatinib.
Sitagliptin Sitagliptin Sitagliptin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Varenicline Varenicline Varenicline may decrease the excretion rate of Telavancin which could result in a higher serum level.
Albuterol Albuterol The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Telavancin.
Paliperidone Paliperidone The risk or severity of QTc prolongation can be increased when Telavancin is combined with Paliperidone.
Bortezomib Bortezomib The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Telavancin.
Clofarabine Injection Clofarabine Injection Clofarabine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Lubiprostone Lubiprostone Lubiprostone may decrease the excretion rate of Telavancin which could result in a higher serum level.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Telavancin.
Posaconazole Posaconazole The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Telavancin.
Primaquine Primaquine The risk or severity of QTc prolongation can be increased when Primaquine is combined with Telavancin.
Pemetrexed Injection Pemetrexed Injection Telavancin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Dimenhydrinate Dimenhydrinate The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Telavancin.
Vorinostat Vorinostat The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Telavancin.
Sorafenib Sorafenib The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Telavancin.
Sunitinib Sunitinib The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Telavancin.
Lapatinib Lapatinib The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Telavancin.
Levocetirizine Levocetirizine The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Telavancin.
Pegaptanib Injection Pegaptanib Injection Pegaptanib may decrease the excretion rate of Telavancin which could result in a higher serum level.
Dasatinib Dasatinib The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Telavancin.
Azacitidine Injection Azacitidine Injection Azacitidine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Lenalidomide Lenalidomide Lenalidomide may decrease the excretion rate of Telavancin which could result in a higher serum level.
Nilotinib Nilotinib The risk or severity of QTc prolongation can be increased when Telavancin is combined with Nilotinib.
Toremifene Toremifene The risk or severity of QTc prolongation can be increased when Telavancin is combined with Toremifene.
Budesonide Budesonide Budesonide may decrease the excretion rate of Telavancin which could result in a higher serum level.
Desmopressin Desmopressin Desmopressin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Doripenem Injection Doripenem Injection Doripenem may decrease the excretion rate of Telavancin which could result in a higher serum level.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Telavancin is combined with Arsenic trioxide.
Desvenlafaxine Desvenlafaxine Telavancin may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.
Cevimeline Cevimeline Cevimeline may decrease the excretion rate of Telavancin which could result in a higher serum level.
Flecainide Flecainide The risk or severity of QTc prolongation can be increased when Flecainide is combined with Telavancin.
Certolizumab Injection Certolizumab Injection Telavancin may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.
Daptomycin Injection Daptomycin Injection Daptomycin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Methylnaltrexone Injection Methylnaltrexone Injection Telavancin may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Midazolam Midazolam Midazolam may decrease the excretion rate of Telavancin which could result in a higher serum level.
Dexrazoxane Injection Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Telavancin which could result in a higher serum level.
Milnacipran Milnacipran Milnacipran may decrease the excretion rate of Telavancin which could result in a higher serum level.
Plerixafor Injection Plerixafor Injection Telavancin may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Fesoterodine Fesoterodine Telavancin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Degarelix is combined with Telavancin.
Betaxolol Betaxolol The risk or severity of QTc prolongation can be increased when Betaxolol is combined with Telavancin.
Iloperidone Iloperidone The risk or severity of QTc prolongation can be increased when Telavancin is combined with Iloperidone.
Prasugrel Prasugrel Prasugrel may decrease the excretion rate of Telavancin which could result in a higher serum level.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
Dronedarone Dronedarone The risk or severity of QTc prolongation can be increased when Telavancin is combined with Dronedarone.
Pralatrexate Injection Pralatrexate Injection Telavancin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection Palonosetron may decrease the excretion rate of Telavancin which could result in a higher serum level.
Saxagliptin Saxagliptin Saxagliptin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Romidepsin Injection Romidepsin Injection The risk or severity of QTc prolongation can be increased when Telavancin is combined with Romidepsin.
Topotecan Topotecan Topotecan may decrease the excretion rate of Telavancin which could result in a higher serum level.
Pazopanib Pazopanib The risk or severity of QTc prolongation can be increased when Telavancin is combined with Pazopanib.
Asenapine Asenapine The risk or severity of QTc prolongation can be increased when Telavancin is combined with Asenapine.
Dalfampridine Dalfampridine Telavancin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
Eribulin Injection Eribulin Injection The risk or severity of QTc prolongation can be increased when Eribulin is combined with Telavancin.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Telavancin which could result in a higher serum level.
Lurasidone Lurasidone The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Telavancin.
Acetaminophen Injection Acetaminophen Injection Acetaminophen may decrease the excretion rate of Telavancin which could result in a higher serum level.
Ipilimumab Injection Ipilimumab Injection Ipilimumab may decrease the excretion rate of Telavancin which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Terbutaline Injection Terbutaline Injection The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Telavancin.
Roflumilast Roflumilast Roflumilast may decrease the excretion rate of Telavancin which could result in a higher serum level.
Rilpivirine Rilpivirine The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Telavancin.
Triptorelin Injection Triptorelin Injection The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Telavancin.
Rivaroxaban Rivaroxaban Rivaroxaban may decrease the excretion rate of Telavancin which could result in a higher serum level.
Ruxolitinib Ruxolitinib Telavancin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
Vandetanib Vandetanib The risk or severity of QTc prolongation can be increased when Telavancin is combined with Vandetanib.
Clobazam Clobazam Clobazam may decrease the excretion rate of Telavancin which could result in a higher serum level.
Vemurafenib Vemurafenib The risk or severity of QTc prolongation can be increased when Telavancin is combined with Vemurafenib.
Deferiprone Deferiprone Telavancin may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Crizotinib Crizotinib The risk or severity of QTc prolongation can be increased when Telavancin is combined with Crizotinib.
Naloxone Injection Naloxone Injection Naloxone may decrease the excretion rate of Telavancin which could result in a higher serum level.
Fondaparinux Injection Fondaparinux Injection Fondaparinux may decrease the excretion rate of Telavancin which could result in a higher serum level.
Enzalutamide Enzalutamide Telavancin may decrease the excretion rate of Enzalutamide which could result in a higher serum level.
Mirabegron Mirabegron The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Telavancin.
Teduglutide Injection Teduglutide Injection Telavancin may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Bedaquiline Bedaquiline The risk or severity of QTc prolongation can be increased when Telavancin is combined with Bedaquiline.
Alogliptin Alogliptin Alogliptin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Pomalidomide Pomalidomide Telavancin may decrease the excretion rate of Pomalidomide which could result in a higher serum level.
Canagliflozin Canagliflozin Telavancin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib Dabrafenib The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Telavancin.
Trametinib Trametinib Telavancin may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran Levomilnacipran Telavancin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
Ertapenem Injection Ertapenem Injection Ertapenem may decrease the excretion rate of Telavancin which could result in a higher serum level.
Vortioxetine Vortioxetine Telavancin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
Ketorolac Injection Ketorolac Injection Ketorolac may decrease the excretion rate of Telavancin which could result in a higher serum level.
Sofosbuvir Sofosbuvir Telavancin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin Dapagliflozin may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
Apremilast Apremilast Apremilast may decrease the excretion rate of Telavancin which could result in a higher serum level.
Droxidopa Droxidopa Droxidopa may decrease the excretion rate of Telavancin which could result in a higher serum level.
Ceritinib Ceritinib The risk or severity of QTc prolongation can be increased when Telavancin is combined with Ceritinib.
Testosterone Injection Testosterone Injection Testosterone may decrease the excretion rate of Telavancin which could result in a higher serum level.
Edoxaban Edoxaban Telavancin may decrease the excretion rate of Edoxaban which could result in a higher serum level.
Methamphetamine Methamphetamine Metamfetamine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Tasimelteon Tasimelteon Telavancin may decrease the excretion rate of Tasimelteon which could result in a higher serum level.
Risperidone Injection Risperidone Injection The risk or severity of QTc prolongation can be increased when Risperidone is combined with Telavancin.
Lenvatinib Lenvatinib The risk or severity of QTc prolongation can be increased when Telavancin is combined with Lenvatinib.
Panobinostat Panobinostat The risk or severity of QTc prolongation can be increased when Telavancin is combined with Panobinostat.
Haloperidol Injection Haloperidol Injection The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Telavancin.
Ivabradine Ivabradine Ivabradine may increase the QTc-prolonging activities of Telavancin.
Amiloride Amiloride Amiloride may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
Macitentan Macitentan Telavancin may decrease the excretion rate of Macitentan which could result in a higher serum level.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Telavancin is combined with Ziprasidone.
Penicillin G Procaine Injection Penicillin G Procaine Injection Telavancin may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Ixazomib Ixazomib Telavancin may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Lesinurad Lesinurad Telavancin may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Telavancin which could result in a higher serum level.
Brivaracetam Injection Brivaracetam Injection Brivaracetam may decrease the excretion rate of Telavancin which could result in a higher serum level.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Telavancin.
Furosemide Injection Furosemide Injection Furosemide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
Lixisenatide Injection Lixisenatide Injection Telavancin may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Ribociclib Ribociclib The risk or severity of QTc prolongation can be increased when Telavancin is combined with Ribociclib.
Doxepin (Insomnia) Doxepin (Insomnia) The risk or severity of QTc prolongation can be increased when Doxepin is combined with Telavancin.
Deutetrabenazine Deutetrabenazine The risk or severity of QTc prolongation can be increased when Telavancin is combined with Deutetrabenazine.
Valbenazine Valbenazine Telavancin may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Naldemedine Naldemedine Telavancin may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Benznidazole Benznidazole Telavancin may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Delafloxacin Delafloxacin The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Telavancin.
Tetrabenazine Tetrabenazine The risk or severity of QTc prolongation can be increased when Telavancin is combined with Tetrabenazine.
Ertugliflozin Ertugliflozin Ertugliflozin may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
Apalutamide Apalutamide Telavancin may decrease the excretion rate of Apalutamide which could result in a higher serum level.
Baricitinib Baricitinib Telavancin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lofexidine Lofexidine The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Telavancin.
Plazomicin Injection Plazomicin Injection Telavancin may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Eliglustat Eliglustat The risk or severity of QTc prolongation can be increased when Telavancin is combined with Eliglustat.
Encorafenib Encorafenib The risk or severity of QTc prolongation can be increased when Telavancin is combined with Encorafenib.
Ivosidenib Ivosidenib The risk or severity of QTc prolongation can be increased when Telavancin is combined with Ivosidenib.
Stiripentol Stiripentol Telavancin may decrease the excretion rate of Stiripentol which could result in a higher serum level.
Gilteritinib Gilteritinib The risk or severity of QTc prolongation can be increased when Telavancin is combined with Gilteritinib.
Glasdegib Glasdegib The risk or severity of QTc prolongation can be increased when Telavancin is combined with Glasdegib.
Prucalopride Prucalopride Telavancin may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Acyclovir Ophthalmic Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Telavancin which could result in a higher serum level.
Solriamfetol Solriamfetol Telavancin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.
Triclabendazole Triclabendazole The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Telavancin.
Entrectinib Entrectinib The risk or severity of QTc prolongation can be increased when Telavancin is combined with Entrectinib.
Pitolisant Pitolisant Telavancin may increase the QTc-prolonging activities of Pitolisant.
Lefamulin Lefamulin Lefamulin may increase the QTc-prolonging activities of Telavancin.
Fostemsavir Fostemsavir The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Telavancin.
Octreotide Octreotide The risk or severity of QTc prolongation can be increased when Octreotide is combined with Telavancin.
Relugolix Relugolix The risk or severity of QTc prolongation can be increased when Relugolix is combined with Telavancin.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
Viloxazine Viloxazine Telavancin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Fenoprofen Fenoprofen Fenoprofen may decrease the excretion rate of Telavancin which could result in a higher serum level.
Indomethacin Indomethacin Indomethacin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Mefenamic Acid Mefenamic Acid Mefenamic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.
Naproxen Naproxen Naproxen may decrease the excretion rate of Telavancin which could result in a higher serum level.
Tolmetin Tolmetin Tolmetin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Sulindac Sulindac Sulindac may decrease the excretion rate of Telavancin which could result in a higher serum level.
Trazodone Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Telavancin.
Isotretinoin Isotretinoin Isotretinoin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Sucralfate Sucralfate Sucralfate may decrease the excretion rate of Telavancin which could result in a higher serum level.
Floxuridine Floxuridine Floxuridine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Metaxalone Metaxalone Metaxalone may decrease the excretion rate of Telavancin which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection Methotrexate may decrease the excretion rate of Telavancin which could result in a higher serum level.
Methsuximide Methsuximide The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Telavancin.
Chlorpromazine Chlorpromazine The risk or severity of QTc prolongation can be increased when Chlorpromazine is combined with Telavancin.
Diazepam Diazepam Diazepam may decrease the excretion rate of Telavancin which could result in a higher serum level.
Oxazepam Oxazepam Oxazepam may decrease the excretion rate of Telavancin which could result in a higher serum level.
Flurazepam Flurazepam Flurazepam may decrease the excretion rate of Telavancin which could result in a higher serum level.
Clorazepate Clorazepate Clorazepic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.
Lorazepam Lorazepam Lorazepam may decrease the excretion rate of Telavancin which could result in a higher serum level.
Carmustine Carmustine Carmustine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Amantadine Amantadine The risk or severity of QTc prolongation can be increased when Amantadine is combined with Telavancin.
Codeine Codeine Codeine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Phenelzine Phenelzine Phenelzine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Tetracycline Tetracycline Tetracycline may decrease the excretion rate of Telavancin which could result in a higher serum level.
Prochlorperazine Prochlorperazine The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Telavancin.
Thioridazine Thioridazine The risk or severity of QTc prolongation can be increased when Telavancin is combined with Thioridazine.
Bleomycin Bleomycin Bleomycin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Sulfadiazine Sulfadiazine Sulfadiazine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Methadone Methadone The risk or severity of QTc prolongation can be increased when Methadone is combined with Telavancin.
Benztropine Benztropine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Telavancin.
Maprotiline Maprotiline The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Telavancin.
Ibuprofen Ibuprofen Ibuprofen may decrease the excretion rate of Telavancin which could result in a higher serum level.
Orphenadrine Orphenadrine The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Telavancin.
Azathioprine Azathioprine Azathioprine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Methylphenidate Methylphenidate Methylphenidate may decrease the excretion rate of Telavancin which could result in a higher serum level.
Amoxapine Amoxapine The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Telavancin.
Sulfasalazine Sulfasalazine Sulfasalazine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Phenazopyridine Phenazopyridine Phenazopyridine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Carbamazepine Carbamazepine Telavancin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Methyldopa Methyldopa Methyldopa may decrease the excretion rate of Telavancin which could result in a higher serum level.
Hydralazine Hydralazine Hydralazine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Cimetidine Cimetidine Cimetidine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Warfarin Warfarin Telavancin may decrease the excretion rate of Warfarin which could result in a higher serum level.
Clonazepam Clonazepam Clonazepam may decrease the excretion rate of Telavancin which could result in a higher serum level.
Loperamide Loperamide The risk or severity of QTc prolongation can be increased when Loperamide is combined with Telavancin.
Promethazine Promethazine The risk or severity of QTc prolongation can be increased when Promethazine is combined with Telavancin.
Meclofenamate Meclofenamate Meclofenamic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.
Nitrofurantoin Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Digoxin Digoxin Telavancin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Chloroquine Chloroquine The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Telavancin.
Quinine Quinine The risk or severity of QTc prolongation can be increased when Telavancin is combined with Quinine.
Ethosuximide Ethosuximide The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Telavancin.
Triamterene Triamterene Triamterene may decrease the excretion rate of Telavancin which could result in a higher serum level.
Chlorothiazide Chlorothiazide Chlorothiazide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
Chlorthalidone Chlorthalidone Chlorthalidone may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
Metolazone Metolazone Metolazone may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide Isosorbide Isosorbide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
Secobarbital Secobarbital Secobarbital may decrease the excretion rate of Telavancin which could result in a higher serum level.
Desipramine Desipramine The risk or severity of QTc prolongation can be increased when Desipramine is combined with Telavancin.
Amitriptyline Amitriptyline The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Telavancin.
Imipramine Imipramine The risk or severity of QTc prolongation can be increased when Imipramine is combined with Telavancin.
Probenecid Probenecid Probenecid may decrease the excretion rate of Telavancin which could result in a higher serum level.
Quinidine Quinidine The risk or severity of QTc prolongation can be increased when Telavancin is combined with Quinidine.
Procainamide Procainamide The risk or severity of QTc prolongation can be increased when Telavancin is combined with Procainamide.
Isoniazid Isoniazid Isoniazid may decrease the excretion rate of Telavancin which could result in a higher serum level.
Pyrazinamide Pyrazinamide Pyrazinamide may decrease the excretion rate of Telavancin which could result in a higher serum level.
Disopyramide Disopyramide The risk or severity of QTc prolongation can be increased when Telavancin is combined with Disopyramide.
Valproic Acid Valproic Acid The risk or severity of QTc prolongation can be increased when Telavancin is combined with Valproic acid.
Tamoxifen Tamoxifen The risk or severity of QTc prolongation can be increased when Tamoxifen is combined with Telavancin.
Butabarbital Butabarbital Butabarbital may decrease the excretion rate of Telavancin which could result in a higher serum level.
Liothyronine Liothyronine Liothyronine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Methimazole Methimazole Methimazole may decrease the excretion rate of Telavancin which could result in a higher serum level.
Chlorpropamide Chlorpropamide Chlorpropamide may decrease the excretion rate of Telavancin which could result in a higher serum level.
Tolbutamide Tolbutamide Tolbutamide may decrease the excretion rate of Telavancin which could result in a higher serum level.
Tolazamide Tolazamide Tolazamide may decrease the excretion rate of Telavancin which could result in a higher serum level.
Baclofen Baclofen Baclofen may decrease the excretion rate of Telavancin which could result in a higher serum level.
Doxylamine Doxylamine The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Telavancin.
Cyproheptadine Cyproheptadine The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Telavancin.
Clemastine Clemastine The risk or severity of QTc prolongation can be increased when Telavancin is combined with Clemastine.
Chlorpheniramine Chlorpheniramine The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Telavancin.
Brompheniramine Brompheniramine The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Telavancin.
Ethambutol Ethambutol Ethambutol may decrease the excretion rate of Telavancin which could result in a higher serum level.
Methyclothiazide Methyclothiazide Methyclothiazide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Telavancin.
Chlorzoxazone Chlorzoxazone Chlorzoxazone may decrease the excretion rate of Telavancin which could result in a higher serum level.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Folic Acid Folic Acid Folic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.
Disulfiram Disulfiram The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Telavancin.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The risk or severity of QTc prolongation can be increased when Propranolol is combined with Telavancin.
Nortriptyline Nortriptyline The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Telavancin.
Spironolactone Spironolactone Spironolactone may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection Amphotericin B Injection Amphotericin B may decrease the excretion rate of Telavancin which could result in a higher serum level.
Phytonadione Phytonadione Phylloquinone may decrease the excretion rate of Telavancin which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Nadolol Nadolol Nadolol may decrease the excretion rate of Telavancin which could result in a higher serum level.
Allopurinol Allopurinol Allopurinol may decrease the excretion rate of Telavancin which could result in a higher serum level.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Telavancin.
Flavoxate Flavoxate Flavoxate may decrease the excretion rate of Telavancin which could result in a higher serum level.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Papaverine is combined with Telavancin.
Fluorouracil Injection Fluorouracil Injection The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Telavancin.
Colchicine Colchicine Colchicine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Telavancin which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Telavancin which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Cephalexin Cephalexin Cephalexin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Dacarbazine Dacarbazine Dacarbazine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Acetazolamide Acetazolamide Acetazolamide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Telavancin which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Ketoconazole Ketoconazole The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Telavancin.
Pyrantel Pyrantel Telavancin may decrease the excretion rate of Pyrantel which could result in a higher serum level.
Ethacrynic Acid Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Telavancin which could result in a higher serum level.
Metoprolol Metoprolol Metoprolol may decrease the excretion rate of Telavancin which could result in a higher serum level.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Telavancin.
Thiothixene Thiothixene The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Telavancin.
Aspirin Aspirin Acetylsalicylic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.
Salsalate Salsalate Salsalate may decrease the excretion rate of Telavancin which could result in a higher serum level.
Alprazolam Alprazolam Alprazolam may decrease the excretion rate of Telavancin which could result in a higher serum level.
Temazepam Temazepam Temazepam may decrease the excretion rate of Telavancin which could result in a higher serum level.
Triazolam Triazolam Triazolam may decrease the excretion rate of Telavancin which could result in a higher serum level.
Dicyclomine Dicyclomine Dicyclomine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Hyoscyamine Hyoscyamine The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Telavancin.
Propantheline Propantheline Propantheline may decrease the excretion rate of Telavancin which could result in a higher serum level.
Trimethoprim Trimethoprim Trimethoprim may decrease the excretion rate of Telavancin which could result in a higher serum level.
Diltiazem Diltiazem The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Telavancin.
Nifedipine Nifedipine The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Telavancin.
Timolol Timolol The risk or severity of QTc prolongation can be increased when Timolol is combined with Telavancin.
Verapamil Verapamil Verapamil may decrease the excretion rate of Telavancin which could result in a higher serum level.
Pindolol Pindolol Pindolol may decrease the excretion rate of Telavancin which could result in a higher serum level.
Cisplatin Injection Cisplatin Injection Telavancin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal Diflunisal Diflunisal may decrease the excretion rate of Telavancin which could result in a higher serum level.
Piroxicam Piroxicam Piroxicam may decrease the excretion rate of Telavancin which could result in a higher serum level.
Bumetanide Bumetanide Bumetanide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
Glipizide Glipizide Glipizide may decrease the excretion rate of Telavancin which could result in a higher serum level.
Indapamide Indapamide The risk or severity of QTc prolongation can be increased when Indapamide is combined with Telavancin.
Amoxicillin Amoxicillin Amoxicillin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Oxacillin Injection Oxacillin Injection Oxacillin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Pentoxifylline Pentoxifylline Pentoxifylline may decrease the excretion rate of Telavancin which could result in a higher serum level.
Pentamidine Injection Pentamidine Injection The risk or severity of QTc prolongation can be increased when Pentamidine is combined with Telavancin.
Ceftriaxone Injection Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Telavancin which could result in a higher serum level.
Labetalol Labetalol Labetalol may decrease the excretion rate of Telavancin which could result in a higher serum level.
Auranofin Auranofin Auranofin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Telavancin.
Gemfibrozil Gemfibrozil Gemfibrozil may decrease the excretion rate of Telavancin which could result in a higher serum level.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Telavancin which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Telavancin which could result in a higher serum level.
Ketoprofen Ketoprofen Ketoprofen may decrease the excretion rate of Telavancin which could result in a higher serum level.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Telavancin which could result in a higher serum level.
Pimozide Pimozide The risk or severity of QTc prolongation can be increased when Telavancin is combined with Pimozide.
Flurbiprofen Flurbiprofen Flurbiprofen may decrease the excretion rate of Telavancin which could result in a higher serum level.
Amiodarone Amiodarone The risk or severity of QTc prolongation can be increased when Telavancin is combined with Amiodarone.
Aztreonam Injection Aztreonam Injection Aztreonam may decrease the excretion rate of Telavancin which could result in a higher serum level.
Buspirone Buspirone Buspirone may decrease the excretion rate of Telavancin which could result in a higher serum level.
Ciprofloxacin Ciprofloxacin The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Telavancin.
Mesalamine Mesalamine Mesalazine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Diclofenac Diclofenac Diclofenac may decrease the excretion rate of Telavancin which could result in a higher serum level.
Fluoxetine Fluoxetine The risk or severity of QTc prolongation can be increased when Telavancin is combined with Fluoxetine.
Nimodipine Nimodipine The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Telavancin.
Clozapine Clozapine The risk or severity of QTc prolongation can be increased when Clozapine is combined with Telavancin.
Estazolam Estazolam Estazolam may decrease the excretion rate of Telavancin which could result in a higher serum level.
Ofloxacin Ofloxacin The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Telavancin.
Didanosine Didanosine Didanosine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Pentostatin Injection Pentostatin Injection Pentostatin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Clarithromycin Clarithromycin The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Telavancin.
Etodolac Etodolac Etodolac may decrease the excretion rate of Telavancin which could result in a higher serum level.
Felodipine Felodipine The risk or severity of QTc prolongation can be increased when Felodipine is combined with Telavancin.
Fosinopril Fosinopril Fosinopril may decrease the excretion rate of Telavancin which could result in a higher serum level.
Nabumetone Nabumetone Nabumetone may decrease the excretion rate of Telavancin which could result in a higher serum level.
Itraconazole Itraconazole The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Telavancin.
Lisinopril Lisinopril Lisinopril may decrease the excretion rate of Telavancin which could result in a higher serum level.
Oxaprozin Oxaprozin Oxaprozin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Sotalol Sotalol The risk or severity of QTc prolongation can be increased when Telavancin is combined with Sotalol.
Bisoprolol Bisoprolol Bisoprolol may decrease the excretion rate of Telavancin which could result in a higher serum level.
Isradipine Isradipine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Telavancin.
Cisapride Cisapride The risk or severity of QTc prolongation can be increased when Telavancin is combined with Cisapride.
Venlafaxine Venlafaxine The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Telavancin.
Fluvoxamine Fluvoxamine Fluvoxamine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Nefazodone Nefazodone Nefazodone may decrease the excretion rate of Telavancin which could result in a higher serum level.
Lamotrigine Lamotrigine The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Telavancin.
Losartan Losartan The risk or severity of QTc prolongation can be increased when Losartan is combined with Telavancin.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Telavancin which could result in a higher serum level.
Tramadol Tramadol Tramadol may decrease the excretion rate of Telavancin which could result in a higher serum level.
Carboplatin Injection Carboplatin Injection Carboplatin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Moexipril Moexipril The risk or severity of QTc prolongation can be increased when Moexipril is combined with Telavancin.
Ifosfamide Injection Ifosfamide Injection Ifosfamide may decrease the excretion rate of Telavancin which could result in a higher serum level.
Nicardipine Nicardipine The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Telavancin.
Bupropion Bupropion Bupropion may decrease the excretion rate of Telavancin which could result in a higher serum level.
Ticlopidine Ticlopidine Ticlopidine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Saquinavir Saquinavir The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Telavancin.
Metformin Metformin Metformin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Dalteparin Injection Dalteparin Injection The therapeutic efficacy of Dalteparin can be decreased when used in combination with Telavancin.
Nisoldipine Nisoldipine Nisoldipine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Lamivudine Lamivudine Lamivudine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Acarbose Acarbose Acarbose may decrease the excretion rate of Telavancin which could result in a higher serum level.
Gemcitabine Injection Gemcitabine Injection Gemcitabine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Ritonavir Ritonavir The risk or severity of QTc prolongation can be increased when Ritonavir is combined with Telavancin.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Telavancin which could result in a higher serum level.
Meropenem Injection Meropenem Injection Meropenem may decrease the excretion rate of Telavancin which could result in a higher serum level.
Clomipramine Clomipramine The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Telavancin.
Fosfomycin Fosfomycin Fosfomycin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Mirtazapine Mirtazapine The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Telavancin.
Topiramate Topiramate Topiramate may decrease the excretion rate of Telavancin which could result in a higher serum level.
Pramipexole Pramipexole Pramipexole may decrease the excretion rate of Telavancin which could result in a higher serum level.
Nelfinavir Nelfinavir The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Telavancin.
Azithromycin Azithromycin The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Telavancin.
Nilutamide Nilutamide Nilutamide may decrease the excretion rate of Telavancin which could result in a higher serum level.
Flutamide Flutamide Flutamide may decrease the excretion rate of Telavancin which could result in a higher serum level.
Propafenone Propafenone The risk or severity of QTc prolongation can be increased when Propafenone is combined with Telavancin.
Tamsulosin Tamsulosin Tamsulosin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Quetiapine Quetiapine The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Telavancin.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Telavancin which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Telavancin which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Telavancin which could result in a higher serum level.
Cetirizine Cetirizine The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Telavancin.
Tolcapone Tolcapone Tolcapone may decrease the excretion rate of Telavancin which could result in a higher serum level.
Citalopram Citalopram The risk or severity of QTc prolongation can be increased when Telavancin is combined with Citalopram.
Capecitabine Capecitabine Capecitabine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Efavirenz Efavirenz The risk or severity of QTc prolongation can be increased when Efavirenz is combined with Telavancin.
Abacavir Abacavir Abacavir may decrease the excretion rate of Telavancin which could result in a higher serum level.
Celecoxib Celecoxib Celecoxib may decrease the excretion rate of Telavancin which could result in a higher serum level.
Rosiglitazone Rosiglitazone Rosiglitazone may decrease the excretion rate of Telavancin which could result in a higher serum level.
Tolterodine Tolterodine The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Telavancin.
Oseltamivir Oseltamivir Oseltamivir may decrease the excretion rate of Telavancin which could result in a higher serum level.
Balsalazide Balsalazide Balsalazide may decrease the excretion rate of Telavancin which could result in a higher serum level.
Nateglinide Nateglinide Nateglinide may decrease the excretion rate of Telavancin which could result in a higher serum level.
Galantamine Galantamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Telavancin.
Rabeprazole Rabeprazole Rabeprazole may decrease the excretion rate of Telavancin which could result in a higher serum level.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists